Head And Neck Cancer

More than 20% of patients undergoing surgery for head and neck cancer are malnourished, according to data published in JAMA Otolaryngology Head & Neck Surgery.

Researchers observed similar outcomes between hypofractionated and conventional radiation therapy among patients with alcohol- and tobacco-associated, locally advanced head and neck cancer, according to phase 3 study results.

White patients and those with nonoropharyngeal cancer and advanced disease appeared more likely to receive immunotherapy for head and neck cancer squamous cell carcinoma, according to study results.

High cardiorespiratory fitness was linked to reductions in head and neck, colon, esophagus, stomach, pancreas, liver, rectum, kidney and lung cancers among men, according to a study published in the British Journal of Sports Medicine.

Delayed initiation of postoperative radiation therapy appeared associated with poorer outcomes among patients with oral cavity cancer, according to results of a cohort study.

The combination of ficlatuzumab and cetuximab extended PFS for patients with pan-refractory recurrent or metastatic head and neck squamous cell carcinoma, according to randomized phase 2 study results.

Individuals with newly diagnosed head and neck squamous cell carcinoma are at high risk for adverse cardiovascular events, results of a retrospective study of U.S. veterans showed.

A gene signature model appeared to predict response to cisplatin chemotherapy among tumor samples from patients with muscle-invasive bladder cancer, according to early-phase study results.

Friends of Cancer Research appointed Edward S. Kim, MD, MBA, FACP, FASCO, to its board of directors.

Black patients in head and neck cancer clinical trials consistently achieved poorer survival than white patients who received the same treatments, according to study results.